J. DeWayne Tooson, MD, president of Tuscaloosa-based GI Associates of West Alabama, shared insights into the lasting effect of the…
Browsing: Covid19
Gastrointestinal (GI) and hepatic manifestations among patients hospitalized with COVID-19 were found not to be associated with increased pneumonia severity…
Although fewer patients visited the emergency department for gastrointestinal bleeding during the pandemic, cases were more severe and disproportionately worse…
COVID-19 GI Resources
COVID-19 GI Resources
In this interview, gastroenterologist and AI researcher Dr. Sravanthi Parasa talks about the big implications for the business of gastroenterology. AI will indeed operate and guide us like a self driving car. In such a world, how would your role evolve as the endoscopist?
In this interview, Sam Holliday talks about their plans to scale across all 50 states by the end of 2022. They also plan to hire gastroenterologists and partner with GI practices. Learn about what’s attracting investor interest in digitization of gastroenterology.
In a data driven world, it’ll become acutely obvious that our system is broken in terms of racial disparity. The drugs we have don’t work for all demographics. GI physician community is quite imbalanced in terms of race. In this interview, Dr. Aja McCutchen shares her story – from the suburbs of Cleveland to leading the field.
As a lab billing and revenue cycle management services provider, we are routinely approached on COVID-19 billing and reimbursement for uninsured patients. In this article, we offer a simple primer on billing claims for uninsured patients and the coding guidelines for billing COVID-19 tests.
US Digestive Health is one the eight private equity backed GI platforms in the country. In this open-ended conversation, Dr. Mehul Lalani (VP, US Digestive), Gabriel Luft (Principal, Amulet Capital Partners), and Jerry Tillinger (CEO, US Digestive Health) talk about how the platform has evolved.